readthroughSign in
CompanyBBOTNasdaqSouth San Francisco, CA

BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics develops RAS-targeting small molecules for KRAS-driven cancers.

SCHEDULE 13G/ANov 13Latest SEC filing
Nov 9Latest story